News | March 14, 2011

Pivotal Ultrasound Breast Cancer Screening Study Completed

Pivotal Ultrasound Breast Cancer Screening Study Completed

March 14, 2011 – A pivotal ROC reader study for automated breast ultrasound cancer screening has been completed. The multi-reader, multi-case (MRMC) study evaluated the sensitivity of the somo•v Automated Breast Ultrasound (ABUS) together with a screening mammogram in detecting breast cancer in women with dense breast tissue

The study was conducted by the University of Chicago for U-Systems.

“For most women, mammography remains the gold-standard for the early detection of breast cancer, but multiple studies have demonstrated that it is not enough for women with dense breast tissue,” said study principal investigator Maryellen Giger, Ph.D., professor of radiology at the University of Chicago. “The primary objective of this reader study was to determine the impact of ABUS on reader (interpreting physician) performance when used in combination with mammography as a screening modality for asymptomatic women with dense breast tissue. This study brings us one step closer to earlier detection of breast cancer using ultrasound as an adjunctive screening tool.”

The study data will be used to support the company’s pre-market approval (PMA) submission to the U.S. Food and Drug Administration (FDA) for the ABUS technology. The company will seek a new indication for using the system in screening women with dense breast tissue. It is currently FDA 510(k)-cleared for adjunctive diagnostic use with mammography.

The Reader Study cases were collected under the Somo•Insight clinical study, which is the largest prospective clinical trial ever undertaken by an ultrasound company. The study was designed to evaluate whether digital mammography in combination with somo•v ABUS is more sensitive than a routine screening mammogram alone in detecting breast cancer in women with dense breast tissue. To date, more than 12,000 women have participated in the study, which is actively recruiting up to 20,000 women at multiple breast imaging centers nationwide. To date, the study has identified a significant number of mammographically negative breast cancers that were subsequently detected by ABUS.

“While ultrasound is a proven tool throughout the diagnosis and treatment of breast cancer, it has not typically been used during the screening process. However, for women with dense breast tissue, several large studies have shown that supplementing mammograms with ultrasound can increase detection from 48 to 97 percent,” said Ron Ho, president and CEO of U-Systems. “New approaches to improve early detection in women with dense breasts are clearly needed.”

A growing body of research demonstrates a strong link between breast density and increased cancer risk – up to four to six times in one study published in the New England Journal of Medicine. Since both dense breast tissue and cancer appear white on a mammogram, it is difficult to detect cancer when there is increased dense breast tissue. As breast density increases, the accuracy of the mammogram decreases.

For more information:,

Related Content

FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
GE Healthcare Introduces Invenia ABUS 2.0
Technology | Ultrasound Women's Health | December 03, 2018
GE Healthcare recently launched the Invenia automated breast ultrasound (ABUS) 2.0 system in the United States. This...
Snoring Poses Greater Cardiac Risk to Women
News | Women's Health | November 29, 2018
Obstructive sleep apnea (OSA) and snoring may lead to earlier impairment of cardiac function in women than in men,...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Women Benefit From Mammography Screening Beyond Age 75
News | Mammography | November 26, 2018
Women age 75 years and older should continue to get screening mammograms because of the comparatively high incidence of...
Arterys Demonstrates AI Cloud-Based Medical Image Analysis Solutions at RSNA 2018
News | Computer-Aided Detection Software | November 26, 2018
Medical imaging software company Arterys will demonstrate its wide-ranging suite of artificial intelligence (AI)-...
Novarad Debuts NovaMG-Pro Mammography Software at RSNA 2018
News | Mammography Reporting Software | November 25, 2018
Novarad Corp. announced new mammography software NovaMG-Pro, specifically for multimodality radiologists that read...
Volpara Solutions Showcases Latest VolparaEnterprise Software Tools at RSNA
News | Mammography | November 21, 2018
Volpara Solutions Inc. will showcase its latest artificial intelligence (AI) updates at the 104th Annual Radiological...